Lexicon Pharmaceuticals Inc (LXRX)

Jun 18, 2025

Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA) | LXRX Stock News - GuruFocus

Jun 18, 2025

Jun 18, 2025

Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA) - TradingView

Jun 18, 2025

Jun 13, 2025

Revenues Not Telling The Story For Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) After Shares Rise 31% - simplywall.st

Jun 13, 2025

Jun 11, 2025

Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple - MarketScreener

Jun 11, 2025

Jun 08, 2025

Lexicon Pharmaceuticals surges 67% following InvestingPro’s Fair Value signal By Investing.com - Investing.com

Jun 08, 2025

Jun 05, 2025

Lexicon Pharmaceuticals at Jefferies Conference: Strategic Partnerships and Pipeline Progress - Investing.com Canada

Jun 05, 2025

May 30, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Shares Bought by Northern Trust Corp - Defense World

May 30, 2025

May 29, 2025

Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025

May 21, 2025

Lexicon Pharmaceuticals, Inc. (LXRX): Analysts See 285% Upside Potential - MSN

May 21, 2025

May 20, 2025

13 Best Multibagger Stocks to Invest in Now - Insider Monkey

May 20, 2025

May 19, 2025

Lexicon (LXRX) Advances Study on Sotagliflozin for Heart Conditions | LXRX Stock News - GuruFocus

May 19, 2025

May 19, 2025

LXRXLexicon Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

May 19, 2025

May 19, 2025

Analysts Just Made A Noticeable Upgrade To Their Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Forecasts - simplywall.st

May 19, 2025

May 17, 2025

Earnings Update: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Just Reported And Analysts Are Boosting Their Estimates - simplywall.st

May 17, 2025

May 17, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance

May 17, 2025

May 15, 2025

Lexicon targets late 2025 Phase 3 start for pilavapadin and expands LX9851 partnership with Novo Nordisk - MSN

May 15, 2025

May 15, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025

May 14, 2025

Lexicon Pharmaceuticals (LXRX) Reports Higher Q1 Revenue and Key Strategic Developments | LXRX Stock News - GuruFocus

May 14, 2025

May 14, 2025

Lexicon Pharmaceuticals (LXRX) Pre-Earnings Options Activity Rev - GuruFocus

May 14, 2025

May 14, 2025

LEXICON PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

May 14, 2025

May 14, 2025

Lexicon Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 14, 2025

May 14, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Shares Bought by Barclays PLC - Defense World

May 14, 2025

May 14, 2025

Lexicon Pharmaceuticals Inc (LXRX) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo Finance

May 14, 2025

May 14, 2025

Lexicon Pharmaceuticals Inc (LXRX) Q1 2025 Earnings Call Highlig - GuruFocus

May 14, 2025

May 14, 2025

Lexicon: Q1 Earnings Snapshot - New Haven Register

May 14, 2025

May 13, 2025

Lexicon Pharmaceuticals (LXRX) Secures Major Licensing Deal with Novo Nordisk - GuruFocus

May 13, 2025

May 13, 2025

Lexicon Pharmaceuticals, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:LXRX) - Seeking Alpha

May 13, 2025

May 13, 2025

Earnings call transcript: Lexicon Q1 2025 beats EPS expectations, stock declines - Investing.com

May 13, 2025

May 13, 2025

Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 13, 2025

May 13, 2025

Lexicon Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025

May 13, 2025

Lexicon Pharmaceuticals Inc (LXRX) Q1 2025 Earnings: EPS Beats E - GuruFocus

May 13, 2025

May 13, 2025

Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates - The Manila Times

May 13, 2025

May 13, 2025

Lexicon Pharmaceuticals Q1 Operating Income USD -25.679 Million - marketscreener.com

May 13, 2025

May 13, 2025

Lexicon Secures Massive $1B Novo Nordisk Partnership While Advancing Breakthrough Pain Drug Trial - Stock Titan

May 13, 2025

May 12, 2025

A Preview Of Lexicon Pharmaceuticals's Earnings - Nasdaq

May 12, 2025

May 07, 2025

Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference - The Manila Times

May 07, 2025

May 06, 2025

Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference | LXRX Stock News - GuruFocus

May 06, 2025

May 06, 2025

Lexicon Pharmaceuticals Announces Exclusive Fireside Chat at HC Wainwright BioConnect Conference - Stock Titan

May 06, 2025

May 06, 2025

Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - The Manila Times

May 06, 2025

May 06, 2025

Lexicon Pharmaceuticals Sets Q1 2025 Earnings Date: Key Financial Updates Coming May 13 - Stock Titan

May 06, 2025

Apr 30, 2025

Carcinoid Syndrome Diarrhea Treatment Market To Reach US$ - openPR.com

Apr 30, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 27, 2025

Lexicon Pharmaceuticals, Inc. (LXRX)Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action & Lead Plaintiff Deadline: April 1, 2019 - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

Top 2 Health Care Stocks That May Crash This Month - Benzinga

Apr 25, 2025

Apr 22, 2025

Form ARS LEXICON PHARMACEUTICALS, For: Dec 31 - StreetInsider

Apr 22, 2025

Apr 09, 2025

Lexicon Pharmaceuticals at Needham Conference: Strategic Shift in Focus By Investing.com - Investing.com Canada

Apr 09, 2025